NL-OMON29754已完成不适用
Atrial specific potassium channels as new drug targets in atrial fibrillation - blockers of IKAch and IK,Ca
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Potassium infusion and atrial fibrillatioEUCTR2011-005525-48-NODiakonhjemmet hospital
已完成
1 期
Blockade of Vascular Potassium Channels During Human EndotoxemiaEndotoxemiaNCT00185003Radboud University Medical Center36
进行中（未招募）
1 期
Do two different types of blood pressure lowering therapy (Calcium Channel Blockers or Angiotensin Converting Enzyme Inhibitor/Angiotensin receptor blockers) have similar effects on reducing Blood pressure levels and variability following acute ischaemic Stroke or TIA (CAARBS): A Feasibility TrialEUCTR2017-002560-41-GBniversity of Leicester14
已完成
1 期
Approved calcium channel blocker in the treatment of fibrodysplasia ossificans progressiva (FOP)fibrodysplasia ossificans progressivaJPRN-UMIN000019348agoya University Graduate School of Medicine5
Unknown
不适用
Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo StudiesCancer of Head and NeckNCT03954691Neuromed IRCCS50